Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk China Resources Pharmaceutical Group Limited per 2025 Jun 30 adalah 260,942.48 MM.
- Nilai operating income untuk China Resources Pharmaceutical Group Limited per 2025 Jun 30 adalah 11,761.39 MM.
- Nilai net income untuk China Resources Pharmaceutical Group Limited per 2025 Jun 30 adalah 2,823.33 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 260,942.48 | 11,761.39 | 2,823.33 |
2025-03-31 | 259,307.87 | 11,873.11 | 3,087.09 |
2024-12-31 | 257,673.26 | 11,984.83 | 3,350.86 |
2024-09-30 | 254,078.15 | 11,766.30 | 3,564.12 |
2024-06-30 | 250,483.04 | 11,557.74 | 3,777.38 |
2024-03-31 | 247,593.46 | 11,299.59 | 3,815.82 |
2023-12-31 | 244,703.88 | 11,031.46 | 3,854.25 |
2023-09-30 | 235,885.11 | 10,716.63 | 3,647.31 |
2023-06-30 | 224,655.85 | 10,268.12 | 3,382.38 |
2023-03-31 | 224,587.35 | 10,180.36 | 3,517.55 |
2022-12-31 | 218,182.99 | 9,741.22 | 3,500.27 |
2022-09-30 | 221,486.84 | 9,863.19 | 3,723.95 |
2022-06-30 | 248,035.04 | 11,017.67 | 4,355.83 |
2022-03-31 | 242,420.60 | 10,430.34 | 4,062.36 |
2021-12-31 | 236,806.17 | 9,843.02 | 3,768.89 |
2021-09-30 | 231,164.83 | 9,762.48 | 3,463.46 |
2021-06-30 | 225,523.49 | 9,681.93 | 3,158.04 |
2021-03-31 | 212,973.26 | 9,508.68 | 3,227.58 |
2020-12-31 | 200,423.02 | 9,335.43 | 3,297.13 |
2020-09-30 | 196,170.54 | 8,725.81 | 3,062.68 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk China Resources Pharmaceutical Group Limited pada 2025 Jun 30 adalah 0.45.
- laba per saham yang terdilusi untuk China Resources Pharmaceutical Group Limited pada 2025 Jun 30 adalah 0.45.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | 0.45 | 0.45 |
2025-03-31 | 0.49 | 0.49 |
2024-12-31 | 0.53 | |
2024-09-30 | 0.57 | 0.56 |
2024-06-30 | 0.60 | 0.59 |
2024-03-31 | 0.61 | 0.60 |
2023-12-31 | 0.61 | |
2023-09-30 | 0.58 | 0.58 |
2023-06-30 | 0.54 | 0.54 |
2023-03-31 | 0.56 | 0.56 |
2022-12-31 | 0.56 | |
2022-09-30 | 0.59 | 0.59 |
2022-06-30 | 0.69 | 0.69 |
2022-03-31 | 0.65 | 0.65 |
2021-12-31 | 0.60 | |
2021-09-30 | 0.55 | 0.55 |
2021-06-30 | 0.50 | 0.50 |
2021-03-31 | 0.51 | 0.51 |
2020-12-31 | 0.52 | |
2020-09-30 | 0.49 | 0.49 |
Arus Kas: Operasi, Investasi, Pendanaan
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | 17,535.51 | -8,887.77 | -16,838.45 |
2024-09-30 | 17,917.57 | -7,342.60 | -14,559.60 |
2024-06-30 | 18,299.62 | -5,797.43 | -12,280.75 |
2024-03-31 | 16,924.75 | -3,932.36 | -8,173.03 |
2023-12-31 | 15,549.89 | -2,067.29 | -4,065.32 |
2023-09-30 | 12,770.48 | -570.80 | -4,417.61 |
2023-06-30 | 10,053.27 | 956.90 | -4,896.32 |
2023-03-31 | 10,355.47 | 27.81 | -6,845.06 |
2022-12-31 | 10,821.14 | -819.24 | -9,126.07 |
2022-09-30 | 10,371.11 | -3,774.06 | -4,857.54 |
2022-06-30 | 10,946.97 | -7,424.68 | -649.91 |
2022-03-31 | 11,894.73 | -8,307.74 | 1,177.73 |
2021-12-31 | 12,842.50 | -9,190.80 | 3,005.38 |
2021-09-30 | 9,844.88 | -5,491.71 | 1,048.59 |
2021-06-30 | 6,847.26 | -1,792.63 | -908.19 |
2021-03-31 | 7,526.78 | -2,023.63 | -3,661.35 |
2020-12-31 | 8,206.30 | -2,254.63 | -6,414.51 |
2020-09-30 | 9,925.62 | -3,238.86 | -7,494.19 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 |
Efektivitas Manajemen
- roa untuk China Resources Pharmaceutical Group Limited pada 2025 Jun 30 adalah 0.01.
- roe untuk China Resources Pharmaceutical Group Limited pada 2025 Jun 30 adalah 0.03.
- roic untuk China Resources Pharmaceutical Group Limited pada 2025 Jun 30 adalah 0.02.
- croic untuk China Resources Pharmaceutical Group Limited pada 2025 Jun 30 adalah -0.05.
- ocroic untuk China Resources Pharmaceutical Group Limited pada 2025 Jun 30 adalah 0.10.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | 0.01 | 0.03 | 0.02 | -0.05 | 0.10 |
2025-03-31 | 0.01 | 0.03 | 0.02 | 0.00 | 0.00 |
2024-12-31 | 0.02 | 0.04 | 0.02 | 0.00 | 0.11 |
2024-09-30 | 0.02 | 0.04 | 0.02 | 0.00 | 0.11 |
2024-06-30 | 0.04 | ||||
2024-03-31 | 0.04 | ||||
2023-12-31 | 0.04 | 0.08 | |||
2023-09-30 | 0.04 | 0.06 | |||
2023-06-30 | 0.04 | ||||
2023-03-31 | 0.04 | ||||
2022-12-31 | |||||
2022-09-30 | 0.00 | ||||
2022-06-30 | 0.00 | 0.00 | |||
2022-03-31 | 0.00 | ||||
2021-12-31 | 0.05 | ||||
2021-09-30 | 0.02 | 0.04 | |||
2021-06-30 | 0.02 | 0.02 | 0.02 | 0.04 | |
2021-03-31 | 0.02 | 0.05 | 0.02 | 0.01 | 0.05 |
2020-12-31 | 0.02 | 0.05 | 0.02 | -0.01 | 0.06 |
2020-09-30 | 0.02 | 0.04 | 0.02 | -0.01 | 0.07 |
Gross Margins
- marjin kotor untuk China Resources Pharmaceutical Group Limited pada 2025 Jun 30 adalah 0.16.
- marjin bersih untuk China Resources Pharmaceutical Group Limited pada 2025 Jun 30 adalah 0.01.
- marjin operasi untuk China Resources Pharmaceutical Group Limited pada 2025 Jun 30 adalah 0.05.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.16 | 0.01 | 0.05 |
2025-03-31 | 0.16 | 0.01 | 0.05 |
2024-12-31 | 0.16 | 0.02 | 0.05 |
2024-09-30 | 0.16 | 0.02 | 0.05 |
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | 0.02 | 0.05 | |
2023-06-30 | 0.02 | 0.05 | |
2023-03-31 | 0.02 | 0.05 | |
2022-12-31 | |||
2022-09-30 | 0.00 | 0.00 | |
2022-06-30 | 0.00 | 0.00 | |
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | 0.15 | 0.01 | 0.04 |
2021-03-31 | 0.16 | 0.02 | 0.04 |
2020-12-31 | 0.16 | 0.02 | 0.05 |
2020-09-30 | 0.16 | 0.02 | 0.04 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |